Back
ESC Premium Access

Physiologically-based pharmacokinetic (PBPK) model predicted versus observed effect of Child Pugh mild and moderate hepatic impairment on betrixaban pharmacokinetics

Session: Optimal surrogate endpoints of drug response
Topic: Anticoagulants
Speaker: Doctor J. Leeds (South San Francisco, US)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Doctor Janet Leeds

South San Francisco (United States of America)
0 follower

5 more presentations in this session

The influence of sarcopenia on bleeding risk in patients with atrial fibrillation undergoing coronary stenting and subsequent triple antithrombotic therapy

Speaker: Doctor K. Tsuchida (Niigata, JP)

Access
Abstract
Slides
Thumbnail

Interaction of statin therapy to angiotensin ii receptor type 1 blockers in erectile dysfunction patients. effect on endothelial function and aortic stiffness

Speaker: Doctor N. Ioakeimidis (Athens, GR)

Access
Abstract
Slides
Thumbnail

Acute and chronic effect of ticagrelor versus clopidogrel on aortic stiffness

Speaker: Associate Professor C. Vlachopoulos (Athens, GR)

Access
Abstract
Slides
Thumbnail

Cilostazol induces regression of carotid plaque in patients with high cardiovascular risk: CLOVER study. A multicenter, randomized trial.

Speaker: Professor K. Cho (Busan, KR)

Access
Abstract
Slides
Thumbnail

Ticagrelor reduced CD40L level in patient with ST-segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention compared with clopidogrel

Speaker: Doctor Z. Li (Jinan, CN)

Access
Abstract
Slides
Thumbnail

Access the full session

Optimal surrogate endpoints of drug response

Speakers: Doctor J. Leeds, Doctor K. Tsuchida, Doctor N. Ioakeimidis, Associate Professor C. Vlachopoulos, Professor K. Cho...
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb